These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 36330654)
1. The impact of intrathecal baclofen on the ability to walk: A systematic review. Lee HP; Win T; Balakrishnan S Clin Rehabil; 2023 Apr; 37(4):462-477. PubMed ID: 36330654 [TBL] [Abstract][Full Text] [Related]
2. Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury. Yoon YK; Lee KC; Cho HE; Chae M; Chang JW; Chang WS; Cho SR Medicine (Baltimore); 2017 Aug; 96(34):e7472. PubMed ID: 28834868 [TBL] [Abstract][Full Text] [Related]
3. Long-term intrathecal baclofen therapy in ambulatory patients with spasticity. Sadiq SA; Wang GC J Neurol; 2006 May; 253(5):563-9. PubMed ID: 16328111 [TBL] [Abstract][Full Text] [Related]
4. Effect of intrathecal baclofen bolus injection on temporospatial gait characteristics in patients with acquired brain injury. Horn TS; Yablon SA; Stokic DS Arch Phys Med Rehabil; 2005 Jun; 86(6):1127-33. PubMed ID: 15954050 [TBL] [Abstract][Full Text] [Related]
5. Early outcomes after intrathecal baclofen therapy in ambulatory patients with multiple sclerosis. Lee BS; Jones J; Lang M; Achey R; Dai L; Lobel DA; Nagel SJ; Machado AG; Bethoux F J Neurosurg; 2018 Oct; 129(4):1056-1062. PubMed ID: 29192855 [TBL] [Abstract][Full Text] [Related]
6. Use of intrathecal baclofen therapy in ambulant children and adolescents with spasticity and dystonia of cerebral origin: a systematic review. Pin TW; McCartney L; Lewis J; Waugh MC Dev Med Child Neurol; 2011 Oct; 53(10):885-95. PubMed ID: 21635230 [TBL] [Abstract][Full Text] [Related]
7. [Intrathecal baclofen therapy and management of severe spasticity]. Naito Y Brain Nerve; 2014 Sep; 66(9):1049-55. PubMed ID: 25200576 [TBL] [Abstract][Full Text] [Related]
8. Intrathecal baclofen for multiple sclerosis related spasticity: A twenty year experience. Sammaraiee Y; Yardley M; Keenan L; Buchanan K; Stevenson V; Farrell R Mult Scler Relat Disord; 2019 Jan; 27():95-100. PubMed ID: 30366276 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the impact of intrathecal baclofen on the walking ability of people with Multiple Sclerosis related spasticity. Sammaraiee Y; Stevenson VL; Keenan E; Buchanan K; Lee H; Padilla H; Farrell RA Mult Scler Relat Disord; 2020 Nov; 46():102503. PubMed ID: 33032053 [TBL] [Abstract][Full Text] [Related]
10. Experience with external pump trial prior to implantation for intrathecal baclofen in ambulatory patients with spastic cerebral palsy. Bleyenheuft C; Filipetti P; Caldas C; Lejeune T Neurophysiol Clin; 2007; 37(1):23-8. PubMed ID: 17418354 [TBL] [Abstract][Full Text] [Related]
11. Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives. Natale M; Mirone G; Rotondo M; Moraci A Clin Neurol Neurosurg; 2012 May; 114(4):321-5. PubMed ID: 22104692 [TBL] [Abstract][Full Text] [Related]
12. Case Series: Intrathecal Baclofen Therapy in Stiff-Person Syndrome. Abbatemarco JR; Willis MA; Wilson RG; Nagel SJ; Machado AG; Bethoux FA Neuromodulation; 2018 Oct; 21(7):655-659. PubMed ID: 29532593 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of intrathecal baclofen in ambulatory multiple sclerosis patients: A single-center experience. Abbatemarco JR; Griffin A; Jones NG; Hartman J; McKee K; Wang Z; Nagel SJ; Machado AG; Bethoux F Mult Scler; 2021 May; 27(6):933-941. PubMed ID: 32662728 [TBL] [Abstract][Full Text] [Related]
14. Outcomes, complications, and dosing of intrathecal baclofen in the treatment of multiple sclerosis: a systematic review. Cozzi FM; Zuckerman D; Sacknovitz A; Gozum N; Syal A; Danisi F; Sukul V Neurosurg Focus; 2024 Jun; 56(6):E14. PubMed ID: 38823049 [TBL] [Abstract][Full Text] [Related]
15. Intrathecal Baclofen Trial Before Device Implantation: 12-Year Experience With Continuous Administration. Pucks-Faes E; Matzak H; Hitzenberger G; Genelin E; Halbmayer LM; Fava E; Fritz J; Saltuari L Arch Phys Med Rehabil; 2019 May; 100(5):837-843. PubMed ID: 31030729 [TBL] [Abstract][Full Text] [Related]
16. Long-term therapy with intrathecal baclofen improves quality of life in children with severe spastic cerebral palsy. Kraus T; Gegenleitner K; Svehlik M; Novak M; Steinwender G; Singer G Eur J Paediatr Neurol; 2017 May; 21(3):565-569. PubMed ID: 28237420 [TBL] [Abstract][Full Text] [Related]
17. Intrathecal baclofen in subjects with spastic hemiplegia: assessment of the antispastic effect during gait. Rémy-Néris O; Tiffreau V; Bouilland S; Bussel B Arch Phys Med Rehabil; 2003 May; 84(5):643-50. PubMed ID: 12736875 [TBL] [Abstract][Full Text] [Related]
18. Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS). Creamer M; Cloud G; Kossmehl P; Yochelson M; Francisco GE; Ward AB; Wissel J; Zampolini M; Abouihia A; Berthuy N; Calabrese A; Loven M; Saltuari L J Neurol Neurosurg Psychiatry; 2018 Jun; 89(6):642-650. PubMed ID: 29326296 [TBL] [Abstract][Full Text] [Related]
19. Best Practices for Intrathecal Baclofen Therapy: Patient Selection. Saulino M; Ivanhoe CB; McGuire JR; Ridley B; Shilt JS; Boster AL Neuromodulation; 2016 Aug; 19(6):607-15. PubMed ID: 27434197 [TBL] [Abstract][Full Text] [Related]
20. Treatment of severe, disabling spasticity with continuous intrathecal baclofen therapy following acquired brain injury: the experience of a tertiary institution in Singapore. Wang ZM; Law JH; King NK; Rajeswaran DK; Soh S; Rao JP; Ng WH; Chua KS Singapore Med J; 2016 Jan; 57(1):8-12. PubMed ID: 26831310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]